Cover Image
市場調查報告書

Treventis Corporation - 產品平台分析

Treventis Corporation - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 311251
出版日期 內容資訊 英文 22 Pages
訂單完成後即時交付
價格
Back to Top
Treventis Corporation - 產品平台分析 Treventis Corporation - Product Pipeline Review - 2014
出版日期: 2014年08月25日 內容資訊: 英文 22 Pages
簡介

Treventis Corporation 是研究開發治療像老年癡呆症和帕金森氏症,亨丁頓舞蹈症等因蛋白質錯誤堆積造成的疾病之治療藥的生物科技企業。

本報告提供Treventis Corporation的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Treventis Corporation的基本資料

Treventis Corporation概要

  • 主要資訊
  • 企業資料

Treventis Corporation:R&D概要

  • 主要的治療範圍

Treventis Corporation:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Treventis Corporation:開發中產品概況

  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Treventis Corporation:藥物簡介

  • TRV-1140
  • TRV-1387
  • TRV-217
  • Small Molecule for Huntingtons Disease
  • Small Molecule for Parkinsons Disease

Treventis Corporation:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Treventis Corporation:總公司和子公司的所在地

附錄

圖表一覽

目錄
Product Code: GMDHC06111CDB

Summary

Global Markets Direct's, 'Treventis Corporation - Product Pipeline Review - 2014', provides an overview of the Treventis Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Treventis Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Treventis Corporation including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Treventis Corporation's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Treventis Corporation's pipeline products

Reasons to buy

  • Evaluate Treventis Corporation's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Treventis Corporation in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Treventis Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Treventis Corporation and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Treventis Corporation
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Treventis Corporation and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Treventis Corporation Snapshot
    • Treventis Corporation Overview
    • Key Information
    • Key Facts
  • Treventis Corporation - Research and Development Overview
    • Key Therapeutic Areas
  • Treventis Corporation - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Treventis Corporation - Pipeline Products Glance
    • Treventis Corporation - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Treventis Corporation - Drug Profiles
    • TRV-1140
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TRV-1387
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TRV-217
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Huntingtons Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Parkinsons Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Treventis Corporation - Pipeline Analysis
    • Treventis Corporation - Pipeline Products by Target
    • Treventis Corporation - Pipeline Products by Route of Administration
    • Treventis Corporation - Pipeline Products by Molecule Type
    • Treventis Corporation - Pipeline Products by Mechanism of Action
  • Treventis Corporation - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Treventis Corporation, Key Information
  • Treventis Corporation, Key Facts
  • Treventis Corporation - Pipeline by Indication, 2014
  • Treventis Corporation - Pipeline by Stage of Development, 2014
  • Treventis Corporation - Monotherapy Products in Pipeline, 2014
  • Treventis Corporation - Preclinical, 2014
  • Treventis Corporation - Discovery, 2014
  • Treventis Corporation - Pipeline by Target, 2014
  • Treventis Corporation - Pipeline by Route of Administration, 2014
  • Treventis Corporation - Pipeline by Molecule Type, 2014
  • Treventis Corporation - Pipeline Products by Mechanism of Action, 2014
  • Treventis Corporation, Other Locations

List of Figures

  • Treventis Corporation - Pipeline by Top 10 Indication, 2014
  • Treventis Corporation - Pipeline by Stage of Development, 2014
  • Treventis Corporation - Monotherapy Products in Pipeline, 2014
  • Treventis Corporation - Pipeline by Top 10 Target, 2014
  • Treventis Corporation - Pipeline by Top 10 Molecule Type, 2014
  • Treventis Corporation - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top